letters & comments

NHC Comments on Patient Engagement in Medical Device Clinical Trials Discussion Document

01/08/2019

Read More

NHC Comments on Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs

12/31/2018

Read More

NHC Letter on State Relief and Empowerment Waivers

12/24/2018

Read More

NHC Comments on Patient-Focused Drug Development Guidance: Methods To Identify What Is Important to Patients and Select, Develop, or Modify Fit-for-Purpose Clinical Outcome Assessments

12/14/2018

Read More

NHC Comments on Accountable Care Organizations Pathways to Success

10/16/2018

Read More

NHC Comments on FDA Standard Core Clinical Outcome Assessments and Endpoints

10/15/2018

Read More

Letter to Secretary Azar on the Administration’s Step Therapy Policy

09/26/2018

Read More

NHC Comments on Medicare Program: Proposed Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs

09/26/2018

Read More

NHC Comments on the FDA’s Draft Guidance on Patient-Focused Drug Development: Collecting Comprehensive and Representative Input

09/11/2018

Read More
1 2 3 4 5 6